LAS VEGAS, NEVADA – Media OutReach – 8 January 2022 – Shortly after VinFast Global EV Day at CES 2022, Artemis DNA, a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic testing that enables precision medicine through early disease detection in the U.S., expressed interest in VinFast EVs VF 6, VF 7, VF 8 and VF 9 by making 100 reservations thereof. Such decision by Artemis DNA shows the confidence of the first Vietnam high-class electric vehicle automaker, VinFast, in being able to satisfy U.S. consumers – the world’s most demanding market.
About VinFast & Vingroup
VinFast – a member of Vingroup – envisioned to drive the movement of global smart electric vehicle revolution. Established in 2017, VinFast owns a state-of-the-art automotive manufacturing complex with globally leading scalability that boasts up to 90% automation in Hai Phong, Vietnam.
Strongly committed to the mission for a sustainable future for everyone, VinFast constantly innovates to bring high-quality products, advanced smart services, seamless customer experiences, and pricing strategy for all to inspire global customers to jointly create a future of smart mobility and a sustainable planet. Learn more at: https://vinfastauto.com.
Established in 1993, Vingroup is one of the leading private conglomerates in the region, with a total capitalization of $35 billion USD from three publicly traded companies (as of November 4, 2021). Vingroup currently focuses on three main areas: Technology and Industry, Services and Social Enterprise. Find out more at: https://www.vingroup.net/en.